Ozanimod linked to histologic healing of moderate, severe ulcerative colitis

SAN DIEGO – A new analysis of phase II research finds that the experimental drug ozanimod prompted histologic healing in ulcerative colitis patients at 8 and 32 weeks. “Ozanimod both induces and...
Source: Family Practice News - Category: Primary Care Source Type: news